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Protective role of the dynamin inhibitor Dynasore
against the cholesterol-dependent cytolysin of
Trueperella pyogenes
Giulio Preta, Virginia Lotti, James G. Cronin, and I. Martin Sheldon1
Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom
ABSTRACT The virulence of many Gram-positive bac-
teria depends on cholesterol-dependent cytolysins
(CDCs), which form pores in eukaryotic cell plasma
membranes. Pyolysin (PLO) from Trueperella pyogenes
provided a unique opportunity to explore cellular
responses to CDCs because it does not require thiol acti-
vation. Sublytic concentrations of PLO stimulated phos-
phorylation of MAPK ERK and p38 in primary stromal
cells, and induced autophagy as determined by protein
light-chain 3B cleavage. Although, inhibitors of MAPK
or autophagy did not affect PLO-induced cytolysis. How-
ever, 10 mM 3-hydroxynaphthalene-2-carboxylic acid-(3,4-
dihydroxybenzylidene)-hydrazide (Dynasore), a dynamin
guanosine 59-triphosphatase inhibitor, protected stromal
cells againstPLO-inducedcytolysis asdeterminedby3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
(85 6 17% versus 50 6 9% cell viability), measuring extra-
cellular ATP, and kinetic assays. This was a generalized
mechanism because Dynasore also protected HeLa cells
against streptolysin O. Furthermore, the effect was revers-
ible, with stromal cell sensitivity to PLO restored within
30 minutes of Dynasore removal. The protective effect of
Dynasore was not conferred by dynamin inhibition, induc-
tion of ERK phosphorylation, or Dynasore binding to PLO.
Rather,Dynasorereducedcellularcholesterolanddisrupted
plasma membrane lipid rafts, similar to positive control
methyl-b-cyclodextrin.Dynasoreisatractabletool toexplore
the complexity of cholesterol homeostasis in eukaryotic
cells and to develop strategies to counterCDCs.—Preta,G.,
Lotti, V., Cronin, J. G., and Sheldon, I. M. Protective role of
the dynamin inhibitor Dynasore against the cholesterol-
dependent cytolysin of Trueperella pyogenes. FASEB J.
29, 1516–1528 (2015). www.fasebj.org
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BACTERIA HAVE DEVELOPED many strategies that impact the
cellular functions of the host; the pore-forming toxins
constitute the largest class of bacterial virulence factors,
comprising approximately 25% of all bacterial protein
toxins (1, 2). The mechanism of action of pore-forming
toxins is simple yet elegant because they form holes in the
plasma membrane, disrupting membrane integrity and
ion homeostasis (3, 4). Cholesterol-dependent cytolysins
(CDCs) are a large family of b-barrel pore-forming toxins
that are produced by Gram-positive bacteria (5, 6). Pore
formation is dependent on the presence of membrane
cholesterol, which functions as the receptor for most
CDCs. Cholesterol binding initiates signiﬁcant secondary
and tertiary structural changes in the CDC monomers,
which leads to the assembly of a large membrane-
embedded b-barrel pore complex. Interestingly, dispa-
rate cell types treated with different CDCs can display
similar physiologic responses, including increase in cyto-
solic calcium, conformational changes, and cytoplasmic
vacuolization (7). The functional signiﬁcance of these
responses as well as the responses at the molecular level is
poorly understood.
Among the less-characterized CDCs, pyolysin (PLO) is
the most important actively secreted virulence factor of
Trueperella pyogenes, which is an opportunistic pathogen
causing mastitis and endometritis in ruminants (8). After
parturition, purulent disease of the endometrium is evi-
dent in up to 40%of dairy cows (9). This infection reduces
milk production and causes infertility, costing U.S. and
European dairy industries $2 billion annually (9). Expo-
sure to high concentrations of CDCs leads to cell death,
which can be either apoptotic or necrotic (10). However,
during infection, in vivo host cells are initially exposed
to sublytic concentrations of CDCs, which may allow
the cells time to respond to the insult. In the present study,
the aimwas to examine the responses induced by sublytic
concentrations of PLO, in regard to 3 major pathways:
1) MAPK, 2) autophagy, and 3) cellular cholesterol.
The MAPK family is a group of highly conserved
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protein-serine/threonine kinases, involved in intracellular
regulation in response to various stresses. The MAPK p38,
JNK, and ERK1/2 are activated as a defense response by
eukaryotic cells to pore-forming toxins (3, 11, 12).
Autophagy is also activated in response to pore-forming
toxins probably to maintain energy supply as cells enter
a quiescent state upon pore formation, while plasma
membranes are repaired (3, 13, 14). Finally, cholesterol
content and intracellular cholesterol trafﬁcking are im-
portant for responses to CDCs becausemodiﬁcation of the
levels ofmembrane cholesterol affects pore formation and
the sensitivity of host cells (15).
In the present study, treatment of primary endometrial
stromal cells with sublytic concentrations of PLO induced
phosphorylation of MAPK and autophagy. However,
inhibitors targeting MAPK or autophagy pathways pro-
vided minimal protection for cells against PLO. Inhib-
itors that conferred durable protection against PLO
were the dynamin guanosine 59-triphosphatase (GTPase)
inhibitor 3-hydroxynaphthalene-2-carboxylic acid-(3,4-
dihydroxybenzylidene)-hydrazide (Dynasore), and the cy-
clodextrin methyl-b-cyclodextrin (MbCD). We previously
showed that cyclodextrins reduce endometrial stromal cell
sensitivity to PLO by decreasing cellular cholesterol con-
tent (15),whereasDynasore impairs cholesterol trafﬁcking
and sterol-sensitive gene transcription in human HeLa
cells and macrophages (16, 17). Moreover, Dynasore
inhibits the entry of several viruses, intracellular bacteria,
and parasites (18–20). In our study, Dynasore not only
protected bovine endometrial stromal cells against PLO
but was also effective with HeLa cells and streptolysin O
(SLO). We provide evidence that Dynasore acts mainly by
targeting lipid rafts and reducing cellular cholesterol.
Dynasore represents an interesting treatment to reduce
cellular cholesterol and will be useful to better understand
the complexity of cholesterol trafﬁcking and homeostasis
for the development of further strategies to limit the im-
pact of CDCs.
MATERIALS AND METHODS
Reagents and inhibitors
Recombinant PLOwas puriﬁed as previously described (21), and
the anti-PLO (a-PLO) goat antiserum (21) was a generous gift
from Professor B. H. Jost (University of Arizona, Tucson, AZ,
USA). Ultrapure LPS was from InvivoGen (Toulouse, France),
whereas SLO,DTT,nigericin, staurosporine, andrapamycinwere
purchased from Sigma-Aldrich (Gillingham, United Kingdom).
The ERK1/2 inhibitor peptide (#328000), p38 inhibitor
SB203580 (#559398), JNK inhibitor II (#420128), MEK1/2 in-
hibitorUO126 (#662005),MEK1 inhibitor PD098059 (#513001),
and dynamin inhibitor 1 Dynasore (#324410) were all purchased
fromCalbiochem(Nottingham,UnitedKingdom).Thedynamin
inhibitor peptide (1775) was purchased from Tocris (R&D Sys-
tems, Minneapolis, MN, USA). The mutant PLO (dsPLO) was a
kind gift from Professor M. Palmer (University of Waterloo,
Waterloo,ON,Canada)andgeneratedaspreviouslydescribed(22).
Endometrial stromal cell isolation and cell culture
Isolation and culture of endometrial stromal cells were per-
formed as described previously (15, 23, 24). In brief, bovine uteri
were collected at a local abattoir, as part of the routine process of
the abattoir, from postpubertal nonpregnant animals with no
evidence of genital disease or microbial infection. Stromal cells
were isolated following enzymatic digestion of the endometrium
and differential adhesion to cell culture plates, with cell purity
veriﬁed as described previously (24). Stromal cells were main-
tained in complete culture medium composed of RPMI-1640
(Gibco, Gaithersburg, MD, USA), 10% fetal bovine serum (FBS;
Gibco), 50 IU/mlpenicillin, 50mg/ml streptomycin, and2.5mg/ml
amphotericin B (all from Sigma-Aldrich). HeLa cells were
purchased from American Type Culture Collection (Manassas,
VA, USA) and grown in DMEM (Gibco) containing 10% FBS,
50 IU/ml penicillin, 50 mg/ml streptomycin, and 2.5 mg/ml
amphotericinB.Cells were incubated at 37°C in air with 5%CO2.
Western blotting
To examine activation of intracellular signaling pathways by
CDCs, endometrial stromal cells were seeded in 6-well tissue
culture plates (Techno Plastic Products AG, Trasadingen,
Switzerland) (53 105/well) and incubated overnight in serum-
free medium before treatment with control medium or medium
containing 50 hemolytic units (HU) of PLO. After treatment, cells
were washed in Dulbecco’s PBS (DPBS; Gibco) and lysed by
adding 150 ml of a solution containing RIPA buffer, protease
inhibitors, and phosphatase inhibitor cocktail 2 and 3 (all from
Sigma-Aldrich). The cell lysate was collected and centrifuged at
80003 g for 10minutes at 4°C, and the protein concentration was
measured by DCAssay (Bio-Rad, Hercules, CA, USA). For protein
detection, Western blotting was performed according to standard
procedures, as described previously (23, 24). The following pri-
mary antibodies were used: rabbit anti-ERK1-2 (#17942; Abcam
Incorporated,Cambridge,MA,USA);mouseanti-diphosphorylated
ERK1/2 (M8159; Sigma-Aldrich); rabbit anti-MAPK p38a
(APO3041SU-N; Acris, Herford, Germany); rabbit anti-MAPK
p38a pThr180/pTyr182 (APO5898PU-N; Acris); rabbit anti-
SAPK/JNK (#9252; Cell Signaling Technology, Danvers, MA,
USA); rabbit anti-p-SAPK/JNK (#9251; Cell Signaling Tech-
nology); rabbit anti a-tubulin (#2125; Cell Signaling Technol-
ogy); rabbit anti-LC3B [(protein light-chain 3B) #2775; Cell
Signaling Technology]; and mouse anti-Dynamin (ab14448;
Abcam Incorporated). After incubation with the appropriate sec-
ondary antibody, immune-reactive bands were visualized by using
Clarity Western ECL Substrate (Bio-Rad) and images collected
using a Chemi-Doc imaging system (Bio-Rad). Quantiﬁcation of
the bands was done using the ImageJ software (National Institutes
of Health, Bethesda, MD, USA), as described previously (25).
Cell survival assays
To speciﬁcally explore the impact of PLO or SLO, 53 104/well
endometrial stromal cells in 24-well tissue culture plates were in-
cubated overnight in 1 ml serum-free medium and then treated
for 1 h with control culture medium or medium containing PLO
or SLOusing the range of concentrations speciﬁed in RESULTS.
Cell survival was assessed by the mitochondria-dependent re-
duction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) to formazan, as described previously (26).
Brieﬂy, for theMTT assay, once the supernatants were removed,
fresh culture medium containing 1 mg/ml MTT was added and
incubated with the cells for 1 h; the medium was then removed,
and the cells were lysed with DMSO for the measurement of
optical density (OD) at 570 nm using a microplate reader
(POLARstar Omega; BMG Labtech, Offenburg, Germany), with
data expressed as the percentage of control cell survival.
The alamarBlue assay was used to examine the kinetics
of cell survival (Pierce, Rockford, IL, USA). AlamarBlue is a
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tetrazolium-based dye, incorporating resazurin and resoruﬁn as
oxidation-reduction indicators that yield colorimetric changes
and a ﬂuorescent signal in response to metabolic activity (27).
Stromal cells were grown in 24-well plates and treated with
100 HU PLO prior to adding alamarBlue reagent. After 1, 2, 4,
and 24hours incubation at 37°C in airwith 5%CO2,ﬂuorescence
was measured at 545/590 nm (excitation/emission), with data
expressed as the percentage of control cell survival.
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Figure 1. PLO induces phosphorylation of MAPK. A) Cytolysis of endometrial stromal cells treated for 1, 2, or 4 hours with the
indicated concentration of PLO, as determined by MTT assay. B) Western blotting analysis of total (t-) and phosphorylated (p-)
ERK1/2, p38, and JNK in endometrial stromal cells treated with 50 HU PLO or 1 mg/ml LPS for the indicated times, with
a-tubulin (TUBA) used as a loading control (CTRL). C) Western blotting analysis of phosphorylation of ERK in endometrial
stromal cells treated with 50 HU PLO or 50 HU dsPLO for the indicated times, with a-tubulin used as a loading control. Data in
graphs are presented as the mean (SD) of 3 independent experiments, and data were analyzed using ANOVA and Dunnett’s post
hoc test. Values differ from control: *P , 0.05; **P , 0.01; ***P , 0.001. D) Western blotting analysis of phosphorylation of ERK
in endometrial stromal cells treated with 50 HU PLO, after 1 hour preincubation with medium alone or medium containing
a-PLO antibody, with a-tubulin used as a loading control.
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Immunoﬂuorescence
Toanalyze the inductionof autophagy, 13104/well stromal cells
were cultured overnight in 8-well chamber slides (BD Bio-
sciences, Oxford, United Kingdom) in complete or serum-free
medium. The following day, cells were treated for 3 hours with
controlmediumormedia containing5, 10, or 20HUPLO,orwith
100 nM rapamycin (Sigma-Aldrich) or 1 mM nigericin po-
tassium ionophore (Sigma-Aldrich) as a positive control to in-
duce autophagy. After treatment, cells were washed with DPBS
and ﬁxed in 4% paraformaldehyde for 30 minutes, the slides
then were rehydrated in PBS for 1 h and blocked with a solution
containing 1% bovine serum albumin (BSA). Slides were in-
cubated overnight with the rabbit anti-LC3B antibody (#2775),
then washed in PBS, after which the secondary Alexa Fluor 594
goat anti-rabbit antibody was added (Molecular Probes, Eugene,
OR,USA) and incubated for 1 h at roomtemperature. The slides
were washed and stained with Vectashield containing DAPI
(Vector Laboratories, Burlingame, CA, USA) and analyzed by
confocal microscopy (LSM; Carl Zeiss, Jena, Germany). For the
analysis of nuclear morphology, stromal cells were treated with
100 HU PLO for 1 hour, in the presence of Dynasore or vehicle,
and stained with Vectashield mounting medium containing
propidium iodide (Vector Laboratories). Morphology of cells
was analyzedwith anOlympusBX51 lightmicroscope (Olympus,
Southend-on-Sea, United Kingdom), and at least 100 cells per
treatment, in 3 independent experiments, were scored for the
presence of nuclei with apoptotic/necrotic phenotype. For the
analysis of lipid rafts, 1 3 104/well endometrial stromal cells or
HeLacellswereculturedovernight in8-well chamber cover slides
in serum-freemedium.The following day, cells were treated with
Dynasore or MbCD before control medium or medium con-
taining 100HUPLOwas added.To stain lipid rafts, the cells were
incubated with cholera toxin B (CTB)-FITC (Sigma-Aldrich) for
30 minutes before ﬁxing in 4% paraformaldehyde and blocking
in 1% BSA. The slides were stained with Vectashield mounting
medium containing propidium iodide and analyzed with an
Olympus BX51 light microscope.
Figure 2. PLO induces activation of autophagy. A) Western blotting analysis of LC3BI-to-LC3BII conversion in endometrial
stromal cells treated for 3 hours with the indicated concentrations of PLO, or with established inducers of autophagy nigericin
and rapamycin, with a-tubulin used as a loading control. The numerical ratio of LC3BII:LC3BI is indicated under each
treatment, with 1 representative experiment of 3 shown. B) Caspase-3 activity in endometrial stromal cells treated with the
indicated concentration of PLO or with nigericin, rapamycin, or staurosporine as a positive control. Assay for caspase-3 was
performed using the ﬂuorogenic substrate DEVD-AMC, and data are reported as a fold of control. Data are presented as the
mean (SD) of 3 independent experiments and analyzed using ANOVA and Dunnett’s post hoc test. Values differ from control:
*P , 0.05; ***P , 0.001. C) Immunocytochemistry analysis of LC3B induction in endometrial stromal cells treated for 3 h with
the indicated concentrations of PLO, rapamycin, or nigericin. DNA is stained blue; LC3B is stained green.
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Hemolytic activity
Todetermine the potency of CDCs, the hemolytic activity of PLO
and SLO was measured using a standard hemolysis assay, as de-
scribedpreviously (15). TodeterminewhetherDynasore protects
red blood cells against CDC-mediated hemolysis, a kinetic he-
molysis assay was used, also as described previously (22). In brief,
horse red blood cells (Oxoid, Basingstoke, United Kingdom) in
a 96-well plate at aﬁnal concentration of 0.5%were incubated for
30 min in DPBS containing vehicle, 2.5 mM MbCD, or 20 mM
Dynasore using 4 replicates per treatment, followed by the addi-
tion of PLO or SLO. Hemolysis was monitored at 25°C, and the
OD620 measured every minute for 40minutes using a microplate
reader (POLARstar Omega). To determine whether Dynasore
binds directly to CDCs to inhibit cell lysis, vehicle, PLO, or SLO
was incubated in DPBS or DPBS containing 20 mMDynasore for
5 or 30 minutes before the addition of 0.5% horse red blood
cells, andmeasurement ofOD620was performedeveryminute for
40 minutes using 4 replicate wells per treatment. The experi-
ments were repeated on 4 independent occasions.
ATP and cholesterol measurement
ATP was measured using the ATP Determination Kit (Molecular
Probes) based on luciferase’s absolute requirement for ATP in
producing light (emission maximum ;560 nm at pH 7.8). Cel-
lular cholesterol content was measured using the Amplex Red
Cholesterol Assay Kit (Invitrogen, Life Technologies, Paisley,
United Kingdom), according to the manufacturer’s instructions.
ELISA
To further explore the role of Dynasore in cell membranes,
stromal cells were treated with 100 ng/ml LPS for 24 hours
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Figure 3. Inhibitor screening of PLO-treated stromal cells. A) Viability of endometrial stromal cells pretreated for 30 minutes with
the indicated concentrations of MAPK inhibitors and then treated with control media or media containing 100 HU PLO. Viability
was assessed by MTT assay, and data are presented as the percentage of control cell survival. B) Cytolysis of endometrial stromal
cells pretreated for 30 min with the indicated concentrations of inhibitors and then treated with 100 HU PLO. Cell survival was
assessed by MTT assay, and data are presented as the percentage of control cell survival. Data in (A) and (B) are presented as the
mean (SD) of 5 independent experiments and were analyzed using ANOVA and Dunnett’s post hoc test. Values differ from 100 HU
PLO treatment: *P , 0.05; **P , 0.01. C) Western blotting analysis of phosphorylation of ERK in endometrial stromal cells
treated with 100 HU PLO, in the presence of the indicated inhibitors, with a-tubulin used as a loading control. D) alamarBlue
assay of endometrial stromal cells treated with the indicated concentration of Dynasore or MbCD for 1 and 24 hours. Data are
presented as the mean (SD) of 4 independent experiments.
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because inﬂammatory mediator secretion in response to LPS
dependson lipid rafts (28).Concentrationsof IL-6and IL-8 incell
culture supernatants were measured by ELISA according to the
manufacturer’s instructions. Bovine IL-6 Screening Set ESS0029
(Thermo Fisher Scientiﬁc, Waltham, MA, USA) and Human
CXCL8/IL-8 DuoSet DY208 (R&D Systems Europe Limited,
Abingdon, United Kingdom) were used as previously described
(28). The Human CXCL8/IL-8 DuoSet was previously validated
for measurement of bovine IL-8 (29).
Short interfering RNA
Primary endometrial stromal cells were transfected with Lipo-
fectamine RNAiMAX Reagent (Invitrogen) and short in-
terfering RNA (siRNA) (designed using Dharmacon siDESIGN
Center; Thermo Fisher Scientiﬁc) targeting Dynamin (sense,
59-GGACAUCGAUGGUAAGAAAUU-39; antisense, 59-UUU-
CUUACCAUCGAUGUCCUU-39), as described previously (23)
In brief, RNAiMAX-RNAi duplex complexes were formed by
adding 50 pmol siRNA to 500 ml Opti-MEM I Reduced Serum
Media (without antibiotics; Invitrogen) in each well of a 6-well
plate. For controls, 50 pmol ON-TARGETplus Non-targeting
siRNA #1 (Dharmacon-Thermo Fisher Scientiﬁc, Loughborough,
United Kingdom) was used instead of the targeted siRNA.
Statistical analysis
Data are presented as the arithmetic mean (SD) of at least 3 in-
dependent experiments. Statistical analyses were performed us-
ingGraphPadPrism, version 5 (La Jolla,CA,USA), anddata were
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analyzed using ANOVA with Dunnett’s post hoc comparison test.
Signiﬁcance was ascribed at P, 0.05.
RESULTS
PLO induces activation of the MAPK pathways
Several members of the CDC family activate MAPK at
sublyticCDCconcentrations (11, 12, 30).To test if PLOwas
able to induce a similar activation, primary endometrial
stromal cells were treated with a range of concentrations of
PLOfor1,2, and4hours to identify a sublytic concentration
(Fig. 1A).Theexperimentwasperformed in stromal cells in
serum-free medium because FBS activates the ERK1/2
pathway (31, 32). According to theMTTdata, the LD50 was
approximately 100HUafter 1hour; therefore, stromal cells
were treatedwitha sublytic concentrationof50HUPLOfor
up to 20 minutes, using LPS as a positive control to induce
phosphorylation of MAPK (23) (Supplemental Fig. 1A).
Treatment with PLO induced a time-dependent phos-
phorylation of ERK1/2 and p38, whereas phosphorylation
of JNK was less evident [Fig. 1B, with quantiﬁcation in the
panel below (n = 3 animals), andSupplemental Fig. 1B]. To
further conﬁrm that the effect on the MAPK pathway was
due to the effect of PLO, cells were treated with the dsPLO,
which is able to bind to cell membranes but does not form
oligomers (22). Indeed, PLO induced more phosphoryla-
tion of ERK1/2 compared with dsPLO (Fig. 1C, with
quantiﬁcation below; n = 3 animals). Moreover, to provide
further evidence for the effect of PLO, PLO was incubated
with the speciﬁcantibodya-PLO,prior to treatmentof cells,
which reduced the phosphorylation of ERK1/2 compared
with PLO treatment alone (Fig. 1D).
PLO induces autophagy
Autophagy is an intracellular catabolic process activated in
stressed cells (33). The autophagic pathway also assists the
elimination of certain intracellular pathogens (34). Fur-
thermore, autophagy is induced in response to some pore-
forming toxins (3). To evaluate if PLO induces autophagy,
endometrial stromal cells were treatedwith 5, 10, or 20HU
PLO, using 2 common activators of autophagy (nigericin
and rapamycin) as positive controls (35, 36). After 3 hours,
cells were collected, and Western blotting was performed
to detect the conversion of the LC3-I form into the pro-
cessed LC3-II, a marker of autophagy activation (37). A
PLO concentration-dependent increase in LC3-II was ob-
served (Fig. 2A) in the absence of apoptosis, as determined
by the lack of caspase-3 activation (Fig. 2B). Moreover,
treatment with PLO induced a punctate distribution of
LC3 in cells, similar to that induced by rapamycin and
nigericin (Fig. 2C), providing further evidence that PLO
induces autophagy.
Dynasore protects against PLO-induced cytolysis
To evaluate the functional effect of activation of theMAPK
pathway, stromal cells were pretreated for 30 minutes with
the speciﬁc inhibitor of p38MAPK SB203580, the ERK1/2
inhibitor peptide, and the JNK inhibitor II, using 3 differ-
ent concentrations (0.1, 1, and10mM), before challenging
cells with a lytic dose of 100HU PLO for 1 h. Although the
p38 and the JNK inhibitors had no signiﬁcant effects (Fig.
3A), surprisingly, inhibition of ERKconferredendometrial
stromal cells with some protection against PLO, which is
theopposite effect forothercells andCDCs(3, 38,39).The
protective effect observed with ERK inhibition might be
explained by the reported proapoptotic role of ERK (40,
41). Thus, to further analyze the prosurvival mechanism,
the MEK1/2 inhibitor UO126 and the MEK1 inhibitor
PD098059 were tested, as well as the autophagy inducers
rapamycin and nigericin, the dynamin inhibitor I Dyna-
sore, and the cyclodextrin MbCD. The last 2 compounds
affect clathrin-dependent endocytosis (42) andcholesterol
homeostasis, respectively (15, 17). Although MEK inhib-
itors and autophagy inducers had limited effects on en-
dometrial stromal cell survival when treated with PLO,
Dynasore protected against cytolysis similar toMbCD (Fig.
3B), which protects against PLO by reducing stromal cell
cholesterol content (15). Dynasore acts as a potent in-
hibitor of clathrin-endocytic pathways that depend on
dynamin, by blocking coated vesicle formation within sec-
onds (43, 44). This protective role of Dynasore was not
linked with reduced phosphorylation of ERK, as demon-
strated by Western blotting analysis (Fig. 3C).
To further characterize the effect of Dynasore and
MbCD on endometrial stromal cells, we ﬁrst evaluated
potentially toxic effects of these inhibitors using concen-
trations ranging from1 to80mMforDynasore and100mM
to 2.5 mM for MbCD. As reported in Fig. 3D, AlamarBlue
assay showed that only concentrations around 80 mM
Dynasore affected cell viability, whereas no toxic effects
were shown by MbCD, even at the highest concentration.
BothDynasore andMbCDconferred resistance to 100HU
PLO for 24 h as demonstrated by alamarBlue assay (Fig.
4A),using 3 concentrationsofDynasore (1, 10, and80mM)
and 3 of MbCD (100 mM and 1 and 2.5 mM). To provide
further evidence that both inhibitors are effective in
Viability of endometrial stromal cells pretreated for 30 minutes with Dynasore or dynamin inhibitor peptide (DIP) before 100 HU
PLO was added. Cell viability was assessed by MTT assay, and data are presented as the mean (SD) of 4 independent experiments,
with data analyzed by ANOVA with Dunnett’s post hoc test. Values differ from 100 HU PLO treatment: *P , 0.05. E) Concentrations
of IL-6 and IL-8 in the supernatant of stromal cells treated for 30 minutes with control medium or medium containing 10 or 40 mM
Dynasore and then treated with control medium or medium containing 100 ng/ml LPS for 24 hours. Data are presented as
the mean (SD) of 4 independent experiments and analyzed by ANOVA with Dunnett’s post hoc test. Values differ from LPS:
***P, 0.001. F) Viability of endometrial stromal cells treated for 48 h with Dynamin siRNA (Dyn siRNA) and with nontargeting siRNA
(NC siRNA) and therefore treated with 100 HU PLO for 1 hour. Cell viability was assessed by MTT assay, and data are presented
as the mean (SD) of 3 independent experiments, with data analyzed by ANOVA with Dunnett’s post hoc test. Values differ from
wild-type (WT) 100 HU PLO treatment. The efﬁciency of knockdown was assessed by Western blotting analysis.
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protecting endometrial stromal cells against PLO-
induced cytolysis, we investigated the ability to prevent
the common effect of pore-forming toxins on target
cells in inducingmembrane permeabilization and rapid
ATP depletion (45). Measurement of ATP showed that
PLO treatment induces an increase of ATP in the su-
pernatant twice the level of the control, but pre-
treatment with Dynasore or MbCD inhibited ATP
depletion from the cells (Fig. 4B).Moreover, propidium
iodide staining revealed that pretreatment with Dynasore
reduced the number of cells with damagednuclei (Fig. 4C),
supporting the concept that Dynasore decreased the cel-
lular sensitivity to PLO.
Dynasore acts on cholesterol content via disruption of
lipid rafts
To exclude the possibility that the protection conferred by
Dynasore was related to binding between Dynasore and
PLO,weperformedastandardkinetichemolysis assaywhere
horse red blood cells were treated with Dynasore alone,
Dynasore and PLO at the same time, or Dynasore followed
after 30minutes by PLO. As shown in Fig. 5A, Dynasore did
not inhibit the action of PLO by direct disruption of the
CDC or by protecting the red blood cells. However, as
expected, MbCD protected red blood cells from PLO-
induced hemolysis (Supplemental Fig. 2A).
Dynasore impairs cholesterol trafﬁcking and transcrip-
tion of sterol-sensitive genes by promoting accumulation
of LDL and free cholesterol within the endolysosomal
network (16, 17). Because cholesterol-enriched lipid
domains are necessary for the invagination of clathrin-
coated pits (42, 46, 47), we hypothesized that Dynasore
reduces cellular cholesterol viadestructionof lipid rafts, to
protect endometrial stromal cells against PLO cholesterol
binding and the following formation of the pore. Control
cells had a cholesterol concentration around 1.2 mM, and
treatment with the sublytic dose of 50 HU PLO did not
signiﬁcantly change cholesterol concentration. However,
Dynasore and MbCD decreased cellular cholesterol con-
centration in the presence or absence of PLO (Fig. 5B).
Washout experiments revealed that the effects of Dyna-
sore and MbCD were reversible because removal of the
inhibitors restores sensitivity to PLO and cholesterol levels
(Fig. 5C and Supplemental Fig. 3) The dynamin inhibitor
peptide was unable to rescue cells from PLO-induced cell
death, which implies that the effect of Dynasore was re-
latedmore to targeting lipid rafts than the GTPase activity
of dynamin (Fig. 5D). Further evidence that Dynasore
targets lipid rafts was reduced production of IL-6 and to
a lesser extent IL-8, when stromal cells were pretreated
withDynasorebefore stimulationwithLPS (Fig. 5E). Short
interference RNA experiments showed that dynamin
knockdown does not confer protection against PLO,
conﬁrming that the effect ofDynasore occurs in adynamin-
independent way (Fig. 5F). To seek more direct evidence
that Dynasore targets lipid rafts, we performed immuno-
cytochemical studies using the lipid raft marker, CTB.
Treatment with Dynasore or MbCD reduced the staining
by CTB, both in control and PLO-treated stromal cells,
implying that the decrease in cholesterol content occurs
via disruption of lipid rafts (Fig. 6).
Protective effect of Dynasore against CDCs is
a generalized mechanism
To test if Dynasore inﬂuences endometrial cell sensitivity to
othermembersof theCDCfamily, endometrial stromalcells
were treated with SLO from Streptococcus pyogenes, which is
not a pathogen of the bovine uterus (9). Following DTT
activation, necessary for all CDCs except PLO and inter-
medilysin, stromal cells were treated with a range of con-
centrations of SLO for 1 hour, and the LD50 was 4HU (Fig.
7A). When endometrial stromal cells were pretreated with
Dynasore or MbCD, before adding 4 HU SLO, increased
cell survival was evident (Fig. 7B). A kinetic hemolysis assay
was also used to conﬁrm that protection of cells was not
related toDynasorebinding toSLO(Supplemental Fig. 2B).
To test if Dynasore protection against CDCs could be
applied to other different types than stromal cells, HeLa
cells were treatedwith a range of concentrations of PLOor
Control
10 µM Dynasore
2500 µM MβCD
100 HU PLO
100 HU PLO +
10 µM Dynasore
100 HU PLO +
2500 µM MβCD
PI CTB MERGED
Figure 6. Dynasore and MbCD target lipid rafts. Lipid raft
staining is shown in endometrial stromal cells pretreated for
30 minutes with 10 mM Dynasore or 2500 mMMbCD and then
treated with control medium or medium containing 100 HU
PLO for 1 hour. Lipid rafts are stained using the CTB-FITC
conjugate. DNA stained red; CTB stained green. One repre-
sentative experiment out of 3 is shown.
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SLO in the presence of Dynasore or MbCD. First, we de-
termined that HeLa cells are sensitive to PLO, as shown in
Fig. 7C, whereas sensitivity to SLO was already reported
(48). Although HeLa cells needed a longer incubation
time (2 h versus 30 minutes) and a higher concentration
(80 mM) of Dynasore compared with endometrial stromal
cells, a protective effect of Dynasore was observed with
HeLa cells both for PLO (Fig. 7D) and SLO (Fig. 7E).
Fluorescence analysis of HeLa cells showed decreased
staining for CTB in Dynasore- and MbCD-treated cells,
implying that the action on lipid rafts is a general mecha-
nism (Fig. 8).
DISCUSSION
The aim of the present study was to examine cellular
responses to sublytic concentrations of PLO. This CDChas
a unique advantage for in vitro studies because PLO is
spontaneously active in vitro, whereas other CDCs require
thiol activation (8). Because T. pyogenes commonly causes
endometritis (9), primarybovineendometrial stromal cells
were used to determine cellular response to PLO, partic-
ularly because these stromal cells are highly sensitive to
PLO (15). Because many pathways are activated by pore-
forming toxins (1, 39), we focused on 3 major areas:
phosphorylation of MAPK, autophagy, and cellular cho-
lesterol. Sublytic concentrations of PLO activated the
MAPK and autophagy pathways in stromal cells. However,
themost strikingobservationwas that thedynaminGTPase
inhibitor Dynasore was protective against stromal cytolysis
caused by PLO, and this effect was evident for SLO and for
HeLa cells. Themechanism of action of Dynasore appears
to be to reduce cellular cholesterol content, and Dynasore
was as effective as MbCD for protection of cells against
CDCs (Fig. 9).
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Figure 7. Protective effect of Dynasore against CDCs is a generalized mechanism. A) Viability of endometrial stromal cells treated
for 1 hour with the indicated concentrations of SLO. Cell survival was assessed by MTT assay. Data are presented as the mean
(SD) of 4 independent experiments and were analyzed using ANOVA with Dunnett’s post hoc test. Values differ from control:
**P , 0.01; ***P , 0.001. B) Viability of endometrial stromal cells pretreated for 30 minutes with the indicated concentrations
of Dynasore or MbCD and then treated with 4 HU SLO. Data are presented as the mean (SD) of 4 independent experiments
and were analyzed using ANOVA with Dunnett’s post hoc test. Values differ from 4 HU SLO treatment: **P , 0.01. C) Viability
of HeLa cells treated for 1 hour with the indicated concentrations of PLO. Cell viability was assessed by MTT assay. Data are
presented as the mean (SD) of 4 independent experiments and were analyzed using ANOVA with Dunnett’s post hoc test. Values
differ from control: *P , 0.05; **P , 0.01; ***P , 0.001. D) Viability of HeLa cells pretreated for 2 hours with the indicated
concentrations of Dynasore or MbCD and then treated with 200 HU PLO. E) Viability of HeLa cells pretreated for 2 hours with
the indicated concentrations of Dynasore or MbCD and then treated with 4 HU SLO. Data in (D) and (E) are presented as the
mean (SD) of 4 independent experiments and were analyzed using ANOVA with Dunnett’s post hoc test. Values differ from 200
HU PLO or 4 HU SLO treatment: *P , 0.05; ***P , 0.001.
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Sublytic concentrations of PLO induced phosphoryla-
tion of p38, ERK, and JNK in stromal cells, as well as in-
duction of the autophagy machinery, as determined by
conversion of LC3BI to LC3BII. However, no substantial
changes in cell survival were observed when speciﬁc
inhibitors or activators of these pathways were tested
against lytic concentration of PLO, suggesting that in-
creased stromal cell survival was achievable only when cells
were incubated with cholesterol-targeting compounds.
The protective effect of the MbCD against PLO, and to
a lesser extent other cyclodextrins, has been noted pre-
viously (15). However, a protective role for Dynasore
against CDCs has not been reported. The protective effect
of Dynasore was also observed using a different toxin
(SLO) and the stable HeLa cell line, suggesting that
modiﬁcation of cellular cholesterol content with Dynasore
is a valid approach to protect against the effect of
bacterial CDCs.
Dynasore acts as a reversible inhibitor of the large
GTPasedynamin,which is essential for clathrin-dependent
coated vesicle formation (43). Cholesterol-enriched lipid
domains are necessary for the invagination of clathrin-
coated pits (46, 47). Thus, we hypothesized that Dynasore
may also inﬂuence the binding of PLO to cholesterol.
Indeed, PLO andmany other CDCs bind and even form
pore-like structures on cholesterol crystals (49), and
cholesterol is the only membrane requirement for all
but 2 CDCs (intermedilysin and vaginolysin) that re-
quire CD59 as well (2, 50, 51). Many studies support
a model where CDC monomers preferentially bind to
lipid rafts, which are microdomains of the plasma
membrane enriched for cholesterol and signaling
molecules (52, 53). The lipid raft model is the result of
intensive studies on the nature of lipid-sterol inter-
actions using a variety of physical methods (54–56),
and nowadays, 2 major observations suggest that
cholesterol-lipid interactions play an important role in
the formation of rafts in animal cell membranes. First,
raft fractions isolated from mammalian cells are found
to be enriched in cholesterol (57). Second, disruption
of cell membrane-associated cholesterol can induce
major changes in the distribution of raft-associated
membrane components (58). Targeting of these
microdomains represents, therefore, a valid strategy to
improve the resistance of eukaryotic cells to CDCs.
Analysis of cholesterol content and immunoﬂuores-
cence using CTB conﬁrmed that Dynasore as well as
MbCD decrease the total cellular cholesterol, via disrup-
tion of lipid rafts. This effect was reversible because the
levels of cholesterol after washout experiments were re-
stored with both inhibitors but in higher levels with
Dynasore than with MbCD.
In addition, Dynasore did not bind directly to CDCs
because coincubation of Dynasore and PLO or SLO did
not affect the kinetics of hemolysis. Presumably the lack
of cellular machinery renders ineffective the protective
action of Dynasore for red blood cells compared with
nucleated stromal cell. Dynamin 1 as well as Dynamin 2
are highly conserved in all vertebrates, including
humans and cattle. The dynamin inhibitor peptide
competitively blocks binding of dynamin to amphiphy-
sin, thus preventing endocytosis (59). However, pre-
treatment with this inhibitor and Dynamin-knockdown
experiments failed to protect endometrial stromal cells
from PLO-induced cell death, supporting the concept
that the effect of Dynasore is mainly related to de-
struction of lipid rafts rather than to inhibition of
dynamin. Further functional evidence for this concept
comes from the observation in the present study that
treatment with Dynasore blocks LPS-induced in-
ﬂammatory responses in stromal cells because lipid rafts
facilitate the LPS response (28, 60). Dynasore could also
inﬂuence cholesterol membrane content via alteration
of cholesterol trafﬁcking because previous studies in-
dicated that dynamin inactivation led to the accumula-
tion of free cholesterol within the late endosomal and
lysosomal compartments (16).
In conclusion, the present study found that Dynasore
provides rapid and reversible protection of cells against
PLO and SLO. There was evidence that Dynasore acted
to reduce cellular cholesterol and disrupted lipid rafts.
We suggest that modiﬁcation of cellular cholesterol
content with Dynasore protects cells against the effects
of CDCs.
Control
80 µM Dynasore
2500 µM MβCD
200 HU PLO
200 HU PLO +
80 µM Dynasore
200 HU PLO +
2500 µM MβCD
PI CTB MERGED
Figure 8. Dynasore and MbCD target lipid rafts in HeLa cells.
Lipid raft staining is shown in Hela cells pretreated for 2 hours
with 80 mM Dynasore or 2500 mM MbCD and then treated
with control medium or medium containing 200 HU PLO for
1 h. Lipid rafts are stained using the CTB-FITC conjugate.
DNA stained red; CTB stained green. One representative
experiment out of 3 is shown.
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Supplemental Information 
 
Suppl. Figure 1.  Pyolysin induces activation of MAPK pathway. (A) Endometrial stromal 
cells were treated for 20 min with the indicated concentration of LPS and after  cells were 
lysed for  Western blotting analysis to detect  phosphorylation of  ERK. was used as loading 
control. (B) Western blotting analysis of MAP kinases activation in endometrial stromal cells 
treated with 50 HU PLO or LPS (1 mg/mL) for the indicated time points in three independent 
experiments.tubulin is used a loading control.   
 
Suppl. Figure 2.  Effect of Dynasore and MCD on haemolysis caused by CDCs.  (A) 
Horse red blood cells were incubated for 30 min at 37 C in media alone or medium   
containing the indicated concentrations of MCD  or Dynasore, and then treated with 50 HU 
PLO. OD620 was measured every minute. Data are presented as the mean of 4 replicates for 
each treatment, and the experiment is typical of 4 independent experiments. (B) Horse red 
blood cells were treated with 10 M Dynasore, Dynasore mixed with SLO, SLO alone, or red 
blood cells were incubated with Dynasore for 30 min and then SLO was applied; OD620 was 
measured every minute. Data are presented as the mean of 4 replicates for each treatment, 
and the experiment is typical of 3 independent experiments. 
 
Suppl. Figure 3.  Effect of Dynasore and MCD washout on lipid rafts staining. Lipid 
rafts staining in HeLa cells pre-treated for 2h with 80 M Dynasore or 2500 M MβCD 
before a washout in DMEM was performed in half of chamber slides for a supplementary 30 
min. Lipid rafts are stained using the CTB-FITC-conjugated. DNA stained red, CTB stained 
green. One representative experiment out of three is shown. 
 
 
 
 



